强迫症治疗的新方法? 有证据表明大麻素和迷幻药物存在
Michael Van Ameringen1, Vidhi Patel2, Beth Patterson1
1Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada; MacAnxiety Research Centre, Hamilton, Ontario, Canada.
Journal of psychiatric research
|November 29, 2025
概括
目前对强迫症 (OCD) 的治疗方法对许多患者无效. 本综述研究了大麻素和迷幻药物,发现大麻素的证据有限,但对于治疗耐药性强迫症患者的 псилоцибин来说是一个有希望的信号.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 强迫症 (OCD) 的病因是复杂的,涉及神经递质失衡.
- 40-60%的强迫症患者是抗治疗的 (TR-OCD),需要新的治疗策略.
- 对于强迫症的现有药物治疗方法在很大一部分患者中缺乏有效性.
研究的目的:
- 对TR-OCD进行关于大麻素和迷幻药物的当前文献进行全面的范围审查.
- 在强迫症治疗中详细说明特定物质的证据,包括大麻素, псилоцибин,LSD,N,N-DMT和MDMA.
- 发现研究缺陷,指导未来的临床研究.
主要方法:
- 关于强迫症的已出版和灰色文献的全面范围审查.
- 在强迫症治疗中包括检查大麻素和迷幻药物的研究.
- 分析来自调查,病例报告和临床试验的证据.
主要成果:
- 有限的证据支持使用大麻素 (合成或天然) 治疗强迫症.
- 一个更强烈的信号表明psilocybin对TR-OCD的潜在疗效.
- 目前的证据主要包括观察性研究和小型试验,缺乏严格的RCT.
结论:
- 需要大量的受控试验来验证TR-OCD中大麻素和迷幻药的疗效.
- 西对抗治疗的强迫症有初步的前景.
- 目前,对于强迫症治疗,大麻素缺乏实质性的证据.
相关概念视频
Operant Conditioning Intervention
438
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
438
Obsessive-Compulsive Disorder
489
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
489
Treatment Strategies for Psychological Disorders
666
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
666
Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
Behavior Therapy
576
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
576
Antidepressant Drugs: MAOIs and Other Agents
774
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
774


